These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3075031)

  • 1. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H; Reuter W; Voigt H; Herrmann W
    Z Gesamte Inn Med; 1989 Feb; 44(3):77-9. PubMed ID: 2728555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM; Samper JC
    Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the preparation Trental].
    Wesołowski J; Hubl S; Szubski J; Weinzieher E; Rykowski H
    Wiad Lek; 1985 Apr; 38(8):551-5. PubMed ID: 3892924
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T
    Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract]   [Full Text] [Related]  

  • 7. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of complex treatment on indicators of lipid metabolism in patients with arteriosclerosis obliterans].
    Polous IuM; Loĭko IK; Kurko VS; Gribenko GP; Golomazov MF
    Vrach Delo; 1986 Jun; (6):4-7. PubMed ID: 3750955
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid metabolism indices of patients with arteriosclerosis obliterans of the lower extremities].
    Satmari VV; Kucher VN; Portugal' AS; Gribenko VV
    Vrach Delo; 1984 Feb; (2):70-1. PubMed ID: 6719877
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
    Kostka-Trabkowa E; Dembińska-Kieć A; Grodzińska L; Bieroń K; Gryglewski RJ
    Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R; Voigt H; Reuter W; Preiss R
    Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical importance of the regional study of blood serum lipids in arteriosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Kontorshchikova KN; Parakhoniak NV
    Patol Fiziol Eksp Ter; 1986; (2):23-5. PubMed ID: 3714313
    [No Abstract]   [Full Text] [Related]  

  • 13. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Parakhoniak NV; Zubova TA
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
    Atroshchenko ES
    Kardiologiia; 1986 Dec; 26(12):106-8. PubMed ID: 3550207
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
    Feruglio FS; Ponte E
    Ric Clin Lab; 1981; 11 Suppl 1():373-9. PubMed ID: 7188125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W; Leube G
    Med Welt; 1979 Sep; 30(37):1367-9. PubMed ID: 502814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pentoxifylline and prostaglandins].
    Poggesi L; Boddi M; Scarti L; Masotti G
    Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.